Reaction
Infusion Related Hypersensitivity Reaction reporting signals
As of the last recalculation, Infusion Related Hypersensitivity Reaction appears in 571 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is OXALIPLATIN (PRR 26.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Oxaliplatin | 49 | 26.2 | 26.3 |
| Infliximab-Dyyb | 20 | 25.8 | 25.8 |
| Paclitaxel (Aibumin-Bound) | 47 | 22.6 | 22.6 |
| Paclitaxel | 52 | 21.0 | 21.0 |
| Fosaprepitant Dimeglumine | 7 | 18.8 | 18.8 |
| Carboplatin | 51 | 16.0 | 16.0 |